tiprankstipranks
JEIL PHARMA HOLDINGS INC. (KR:002620)
:002620
South Korea Market
002620
JEIL PHARMA HOLDINGS INC.
RESEARCH TOOLSreports

JEIL PHARMA HOLDINGS INC. (002620) Financial Statements

― Followers

JEIL PHARMA HOLDINGS INC. Financial Overview

JEIL PHARMA HOLDINGS INC.'s market cap is currently ₩117.90B. The company's EPS TTM is ₩549.73; its P/E ratio is 13.97; and it has a dividend yield of 0.91%. JEIL PHARMA HOLDINGS INC. is scheduled to report earnings on August 7, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 657.61B₩ 779.82B₩ 804.04B₩ 792.96B₩ 762.57B
Gross Profit₩ 226.27B₩ 206.52B₩ 214.58B₩ 180.48B₩ 180.51B
Operating Income₩ 15.07B₩ -11.56B₩ 20.92B₩ -7.55B₩ 1.55B
EBITDA₩ 30.02B₩ -38.65B₩ 9.25B₩ -67.00B₩ 6.14B
Net Income₩ 14.64B₩ -51.16B₩ -16.25B₩ -83.15B₩ -12.87B
Balance Sheet
Cash & Short-Term Investments₩ 79.31B₩ 75.88B₩ 59.13B₩ 53.40B₩ 47.22B
Total Assets₩ 876.04B₩ 890.43B₩ 880.00B₩ 865.68B₩ 892.42B
Total Debt₩ 167.37B₩ 155.21B₩ 214.14B₩ 162.62B₩ 115.07B
Net Debt₩ 111.18B₩ 95.39B₩ 177.10B₩ 127.86B₩ 86.49B
Total Liabilities₩ 407.55B₩ 453.04B₩ 477.81B₩ 445.88B₩ 392.11B
Stockholders' Equity₩ 318.74B₩ 306.95B₩ 319.46B₩ 337.76B₩ 411.73B
Cash Flow
Free Cash Flow₩ -7.89B₩ -2.32B₩ -14.25B₩ -42.21B₩ -10.33B
Operating Cash Flow₩ 390.26M₩ 4.54B₩ -4.42B₩ -20.80B₩ 13.40B
Investing Cash Flow₩ -13.44B₩ 2.27B₩ -13.43B₩ -17.56B₩ 7.33B
Financing Cash Flow₩ 10.02B₩ 14.22B₩ 20.62B₩ 44.91B₩ -12.24B
Currency in KRW

JEIL PHARMA HOLDINGS INC. Earnings and Revenue History

Income Statement >

JEIL PHARMA HOLDINGS INC. Debt to Assets

Balance Sheet >

JEIL PHARMA HOLDINGS INC. Cash Flow

Cash Flow >

JEIL PHARMA HOLDINGS INC. Forecast EPS vs Actual EPS

Earnings >